Christina Lake Cannabis Announces Filing of Audit Financial Statements
Christina Lake Cannabis (CSE: CLC) has announced the filing of its audited financial statements, management discussion and analysis, and CEO/CFO certifications for the fiscal year ended February 28, 2025 on SEDAR+.
Following this filing, the company expects the management cease trade order issued on July 2, 2025, to be revoked, which will allow directors and officers to resume trading in company securities.
Christina Lake Cannabis (CSE: CLC) ha annunciato il deposito dei suoi bilanci revisionati, della relazione sulla gestione e analisi, e delle certificazioni del CEO/CFO per l'esercizio chiuso al 28 febbraio 2025 su SEDAR+.
Dopo questo deposito, la società prevede che l'ordine di sospensione del commercio emesso il 2 luglio 2025 venga revocato, permettendo così ai direttori e agli amministratori di riprendere la negoziazione dei titoli della società .
Christina Lake Cannabis (CSE: CLC) ha anunciado la presentación de sus estados financieros auditados, el análisis y discusión de la administración, y las certificaciones del CEO/CFO para el año fiscal finalizado el 28 de febrero de 2025 en SEDAR+.
Tras esta presentación, la compañÃa espera que la orden de suspensión de comercio emitida el 2 de julio de 2025 sea revocada, lo que permitirá a los directores y ejecutivos reanudar la negociación de valores de la empresa.
Christina Lake Cannabis (CSE: CLC)ëŠ� 2025ë…� 2ì›� 28ì� 종료ë� 회계연ë„ì—� 대í•� ê°ì‚¬ ìž¬ë¬´ì œí‘œ, ê²½ì˜ì§� í† ë¡ ë°� ë¶„ì„, CEO/CFO ì¸ì¦ì„œë¥¼ SEDAR+ì—� ì œì¶œí–ˆë‹¤ê³� 발표했습니다.
ì� ì œì¶œ í›� 회사ëŠ� 2025ë…� 7ì›� 2ì¼ì— 발행ë� 거래 중지 ëª…ë ¹ì� í•´ì œë˜ì–´ ì´ì‚¬ ë°� ìž„ì›ë“¤ì´ 회사 ì¦ê¶Œ 거래ë¥� 재개í•� ìˆ� ìžˆì„ ê²ƒìœ¼ë¡� ê¸°ëŒ€í•˜ê³ ìžˆìŠµë‹ˆë‹¤.
Christina Lake Cannabis (CSE : CLC) a annoncé le dépôt de ses états financiers audités, de l’analyse de la gestion et des certifications du CEO/CFO pour l’exercice clos au 28 février 2025 sur SEDAR+.
Suite à ce dépôt, la société s’attend à ce que l�ordonnance de cessation de négociation émise le 2 juillet 2025 soit levée, permettant ainsi aux administrateurs et dirigeants de reprendre la négociation des titres de la société.
Christina Lake Cannabis (CSE: CLC) hat die Einreichung ihrer geprüften Jahresabschlüsse, der Management-Diskussion und -Analyse sowie der CEO/CFO-Zertifizierungen für das am 28. Februar 2025 endende Geschäftsjahr bei SEDAR+ bekannt gegeben.
Nach dieser Einreichung erwartet das Unternehmen, dass die am 2. Juli 2025 erlassene Handelsaussetzung aufgehoben wird, was den Direktoren und Führungskräften erlaubt, den Handel mit Unternehmenswertpapieren wieder aufzunehmen.
- Management cease trade order expected to be lifted
- Company has become compliant with filing requirements
- Company was previously under a management cease trade order due to delayed financial filings
VANCOUVER, British Columbia, July 04, 2025 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is pleased to confirm that further to its news release dated July 2, 2025, the Company has filed on SEDAR+ its audited financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the year ended February 28, 2025 (the “Annual Filings�). The Annual Filings can be obtained on the Company’s SEDAR+ profile at .
As a result of the completion of the Annual Filings, the Company expects that the management cease trade order formerly granted on July 2, 2025, by the applicable securities regulatory authorities, will be revoked and that the Company’s directors and officers will once again be permitted to trade in the Company’s securities.
ABOUT CLC
Christina Lake Cannabis is a licensed producer of cannabis under the Cannabis Act. It has secured a standard cultivation license and corresponding processing amendment from Health Canada (March 2020 and August 2020, respectively) as well as a research and development license (early 2020). Christina Lake Cannabis� facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. Christina Lake Cannabis also owns a 99-acre plot of land adjoining its principal site. CLC focuses its production on creating high quality extracts and distillate for its B2B client base with proprietary strains specifically developed for outdoor cultivation to enhance extraction quality.
For more information about CLC, please visit: www.christinalakecannabis.com
Jennifer Smith
Investor Relations and Media Inquiries
902-229-7265
Forward Looking Information and Risk Factors
This news release contains statements and information that may constitute "forward-looking information" within the meaning of applicable securities legislation, including statements identified by the use of words such as "will", "expects", "positions", "believe", "potential" and similar words, including negatives thereof, or other similar expressions concerning matters that are not historical facts.
Such forward-looking information is not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information contained herein may include, but is not limited to, statements regarding the Company’s expectations that the completion of the Annual Filings will satisfy its continuous disclosure obligations; and that, as a result, the management cease trade order granted on July 2, 2025, will be revoked and directors and officers of the Company will be permitted to trade securities of the Company.
By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. Some of these risks include, but are not limited to, the risk that the Annual Filings do not meet applicable regulatory requirements, that the cease trade order is not revoked as expected, and that trading by directors and officers remains restricted for longer than anticipated.
Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.
In connection with the forward-looking information contained in this news release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information contained in this news release are made as of the date of this news release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice.
